Unknown

Dataset Information

Prognostic Value of Baseline and Soluble ST2 Change in Patients With Light Chain Cardiac Amyloidosis.


ABSTRACT:

Background

The prognostic significance of dynamic changes in soluble suppression of tumorigenicity-2 (sST2) in patients with light chain cardiac amyloidosis (AL-CA) remains unclear. We aimed to evaluate the prognostic significance of both baseline sST2 and 30-day changes (ΔsST2) in patients with light chain cardiac amyloidosis.

Methods

Patients diagnosed with light chain cardiac amyloidosis in Heart Failure Center, Fuwai Hospital (October 2015-May 2024) were enrolled in the entire cohort, with baseline sST2 measured. A prospective subcohort (October 2023-May 2024) also underwent 30-day repeat sST2 measurement. ΔsST2 was defined as the sST2 level at 30 days minus baseline sST2. The primary outcome was all-cause mortality. Prognostic value of both baseline and ΔsST2 was assess

SUBMITTER: Xin A 

PROVIDER: S-EPMC12826881 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature